Acquisition - January 13, 2026
Novartis buys radioligand peptide program from PepLib
Novartis agreed to pay USD 50 million in cash upfront (plus undisclosed milestones) for a peptide‑based radioligand oncology program from Zonsen PepLib Biotech.
Acquisition - December 14, 2025
Sobi to acquire Arthrosi Therapeutics
Sobi will pay USD 950 million upfront in cash to acquire Arthrosi, together with up to USD 550 million in cash in clinical, regulatory and sales milestones.
Acquisition - December 10, 2025
LINK Medical transfers selected operations previously part of SDS Life Science
LINK Medical has announced the transfer of specific business areas from SDS Life Science (an affiliate of Cytel), namely the Drug Development Consulting and Clinical Project Management/Medical Writing units.
Acquisition - December 2, 2025
AddLife acquires Pharmacold and Opitek International
Pharmacold is a Danish specialist in refrigeration technology and service for the pharmaceutical and healthcare sectors and Opitek International is a manufacturer specializing in patient positioning.
Acquisition - November 17, 2025
Lundbeck submits proposal to acquire Irish Avadel
Lundbeck confirms that it has submitted a non-binding proposal to acquire Avadel.
Acquisition - November 7, 2025
The takeover offer of Bavarian Nordic is withdrawn and will not be completed
Earlier this autumn the company announced a takeover offer to acquire all of the issued and outstanding shares in Bavarian Nordic by Innosera, a company controlled by Nordic Capital Fund XI and funds managed and advised by Permira Beteiligungsberatung. The offeror has now informed Bavarian Nordic that, as the minimum acceptance condition has not been satisfied, […]
